RYTHM Inc Dossier - Source-backed chat

RYTHM Inc

RYMNASDAQ

SectorConsumer Staples

IndustryTobacco

Beta (adjusted)1.00

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $20.00Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $43M

Enterprise Value $90.3M

Shares Outstanding 2.1M diluted

Next Earnings Date10 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

RYTHM, Inc. (formerly Agrify Corporation) has successfully pivoted from its capital-intensive legacy extraction hardware business to a high-margin, asset-light brand licensing and hemp-derived THC consumer platform. The cornerstone of this transformation is the April 1, 2026 amendment to its licensing agreements with Green Thumb Industries, which transitions variable royalties into a highly predictable, fixed annual cash fee of $70 million (subject to a double-CPI escalator). This contractually secured cash flow provides immense revenue visibility and financial stability that is virtually unmatched in the micro-cap THC space. Combined with a strong cash balance of $33.3 million as of Q1 2026 and sequential revenue growth of 24% in its continuing operations, RYTHM is exceptionally well-positioned to capture the rapidly expanding market for hemp-derived THC beverages and CPG brands.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$15.0020%

In the bear case, a potential federal ban or severe restriction on hemp-derived THC products significantly impairs the distribution and sales of the Señorita beverage brand and the 1777 spirit. Additionally, any operational or financial distress at Green Thumb Industries that threatens its ability to service the $70 million annual licensing fee would severely impact RYTHM's primary revenue stream. High stock volatility and regulatory uncertainty could compress valuation multiples, leading to a decline in the share price.

Base CaseCentral scenario

$35.0050%

In the base case, RYTHM's financial performance is anchored by the $70 million annual fixed licensing fee from Green Thumb Industries, which provides a highly stable and predictable cash flow stream. The company maintains its asset-light operating model, keeping overhead low while continuing to support its core beverage brands. Sequential growth in the beverage segment remains steady at 15-20% annually. The stock is valued primarily on a multiple of its contractually secured cash flows, supporting a steady upward trajectory from current levels as the market gains confidence in the sustainability of the pivot.

Bull CaseUpside scenario

$45.0030%

In the bull case, RYTHM successfully scales its proprietary hemp-derived THC beverage portfolio (such as Señorita and the newly launched 1777 non-alcoholic spirit) through major mainstream retail partnerships (e.g., Navy Pier, Opry Entertainment Group, Circle K, and Total Wine). Concurrently, Green Thumb Industries continues to aggressively expand the footprint of licensed brands (RYTHM, incredibles, Beboe, Dogwalkers) across legal state markets, ensuring the long-term viability of the licensing agreement. Operating margins expand dramatically due to the asset-light, high-margin nature of fixed licensing fees, driving substantial positive free cash flow and leading to a significant upward re-rating of the stock.

Scenarios reflect our research view at the research date.

Key Investment Merits

Predictable, high-margin recurring revenue stream of $70 million annually from Green Thumb Industries, secured by a double-CPI escalator.
Asset-light business model following the complete wind-down of the legacy, capital-intensive Extraction Business.
Strong balance sheet with $33.3 million in cash and cash equivalents as of March 31, 2026.
Differentiated portfolio of leading, consumer-trusted THC brands (RYTHM, incredibles, Beboe, Dogwalkers, Señorita) with established national footprints.

Key Investment Risks

High concentration of revenue tied to a single counterparty (Green Thumb Industries).
Evolving and highly uncertain state and federal regulatory landscape for hemp-derived THC beverages.
Extreme historical stock price volatility (high beta).

Thesis Invalidation Triggers

Any default or material renegotiation of the $70 million annual licensing fee by Green Thumb Industries.
Passage of federal legislation that effectively bans or severely restricts hemp-derived THC beverages nationwide.
Significant cash burn or unexpected capital allocation away from the asset-light licensing model.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.